CRBU
Caribou Biosciences Inc
NASDAQ: CRBU · HEALTHCARE · BIOTECHNOLOGY
$1.88
-2.08% today
Updated 2026-04-30
Market cap
$205.84M
P/E ratio
—
P/S ratio
18.45x
EPS (TTM)
$-1.59
Dividend yield
—
52W range
$1 – $4
Volume
1.4M
Caribou Biosciences Inc (CRBU) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
-4.2%
Last 4 quarters
Revenue YoY growth
+89.7%
Most recent quarter
EPS YoY growth
+28.2%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-3.6%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-11.9%
2025-11-13
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-16 | $-0.28 | +13.3% | $1.88 | $1.97 | +4.8% |
| 2025-11-13 | $-0.30 | +14.3% | $2.26 | $1.99 | -11.9% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.32 | $-0.28 | +13.3% | $3.94M | +89.7% |
| 2025-09-30 | $-0.35 | $-0.30 | +14.3% | $2.20M | +8.6% |
| 2025-06-30 | $-0.39 | $-0.58 | -48.7% | $2.67M | -23.0% |
| 2025-03-31 | $-0.45 | $-0.43 | +4.4% | $2.35M | -3.1% |
| 2024-12-31 | $-0.42 | $-0.39 | +7.1% | $2.08M | -41.6% |
| 2024-09-30 | $-0.45 | $-0.38 | +15.6% | $2.02M | -91.4% |
| 2024-06-30 | $-0.46 | $-0.42 | +8.7% | $3.46M | -7.7% |
| 2024-03-31 | $-0.40 | $-0.46 | -15.0% | $2.43M | -30.6% |
| 2023-12-31 | $-0.37 | $-0.39 | -5.4% | $3.56M | — |
| 2023-09-30 | $-0.42 | $-0.12 | +71.4% | $23.66M | — |
| 2023-06-30 | $-0.49 | $-0.48 | +2.0% | $3.75M | — |
| 2023-03-31 | $-0.49 | $-0.46 | +6.1% | $3.50M | — |
Frequently asked questions
Has Caribou Biosciences Inc beaten earnings estimates?
Caribou Biosciences Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of -4.2% over the last 4 quarters.
How does CRBU stock react to earnings?
CRBU stock has moved an average of -3.6% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Caribou Biosciences Inc's revenue growth rate?
Caribou Biosciences Inc reported year-over-year revenue growth of +89.7% in its most recent quarter, with EPS growing +28.2% year-over-year.